RESPeRATE: Our Response To The COVID-19 Pandemic.

Our Response To COVID-19

RESPeRATE is responding to the coronavirus disease (COVID-19) pandemic with the safety of our patients and associates worldwide as our primary concern. We are also contributing to global research efforts, and we are ensuring the ongoing support and supply of our products.

Our Commitment to Patients and Caregivers

RESPeRATE is working with patients and caregivers worldwide to understand and discover new ways to improve people’s lives. Only by working together can we improve lives and advance the practice of medicine.

We are committed to actively seeking input from patients and caregivers, and to base inform our decisions with insights throughout the development and commercialization process of our products.

We recognize that the results of clinical experience and clinical trials should be used to advance the practice of medicine in combating COVID-19.

Enhancing Engagement and Support of Patients and Caregivers

RESPeRATE is working to ensure the ongoing support and supply of our products, enhance our customer engagement, to support, and protect the integrity of clinical trials during the coronavirus disease (COVID-19) pandemic.

All RESPeRATE manufacturing sites, distribution sites, and our major suppliers are currently operational.

Working Closely with Healthcare Professionals

RESPeRATE is working closely with healthcare professionals during the coronavirus disease (COVID-19) pandemic. We are embracing new approaches to working together.

Clinical Case Reporting and Clinical Trials with Healthcare Professionals

RESPeRATE is assessing the ongoing clinical experience of our products, and we are actively seeking input and the perspectives of patients, caregivers, and healthcare professionals.

We are developing clinical case reports in accordance with international consensus-based guidelines for high-quality data, precision, completeness, and transparency.

We are providing our products to investigator-initiated trials (IITs) upon request. And in partnership with the research community, RESPeRATE is assessing whether our approved products could be repurposed beyond their approved indications to treat complications of COVID-19.

To Learn More about Our Clinical Case Reporting and Clinical Trials

You may contact a RESPeRATE Medical Information Specialist by calling 1-800-220-1925, or by emailing [email protected].

When contacting us by email, you agree that we may reply to you using regular email, which may not be entirely secure from interception.

This communication is for US patients, caregivers, and healthcare professionals to provide current, accurate, scientific information about our products. It is prepared by RESPeRATE Inc. and is not intended for promotional purposes, nor for medical advice.